28-05-2025
Longevity Health extends cash runway into 1Q26
Longevity Health (XAGE) Holdings announced the sale of 479,621 shares of its common stock at an average price of $4.08 per share through its at-the-market equity offering facility. Gross proceeds from the ATM sales totaled approximately $1.96M, prior to deducting fees and expenses. Assuming no growth beyond the Company's pro forma consolidated FY24 sales and not factoring in the planned 20/20 merger, this financing extends XAGE's cash runway into Q1 FY26.
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders' Hot Stocks on TipRanks >>
Read More on XAGE:
Disclaimer & DisclosureReport an Issue
Longevity Health Gains Nasdaq Approval for Listing
Longevity announces continued Nasdaq listing to complete 20/20 BioLabs deal
Longevity Health reports unaudited Q1 revenue $663,000, up 8% year-over-year
Longevity Health Holdings Inc trading halted, news pending
Longevity Health Implements Reverse Stock Split
